PTCL
Clinical trials for PTCL explained in plain language.
Never miss a new study
Get alerted when new PTCL trials appear
Sign up with your email to follow new studies for PTCL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for refractory lymphoma: tailored drug cocktail targets resistant cancer
Disease control Not yet recruitingThis study tests a personalized combination of drugs for people with a type of lymphoma (PTCL) that did not respond to initial chemotherapy. Researchers will use genetic information from each patient's tumor to select the best drug combination, including an experimental drug call…
Matched conditions: PTCL
Phase: PHASE1, PHASE2 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New drug aims to keep rare lymphoma in check after initial treatment
Disease control Not yet recruitingThis study tests the drug SHR2554 as a maintenance therapy for people with peripheral T-cell lymphoma (PTCL) who have responded to their first treatment. The goal is to see if taking this drug can help keep the cancer from coming back longer. About 30 adults whose cancer is in re…
Matched conditions: PTCL
Phase: PHASE2 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated May 06, 2026 16:13 UTC